BGNE
BeiGene Ltd Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website beigene.com
- Employees(FY) 10000
- ISIN US07725L1026
Performance
1W
1M
3M
6M
YTD
1Y
Profile
Investment Analysis Report: BGNE
Overview
BGNE is a pharmaceutical company operating in the Health Technology sector with a market capitalization of $13.94 billion. The company specializes in Pharmaceuticals: Major and has shown consistent growth over the past few years. In this report, we will conduct a comprehensive analysis of BGNE's financia...
Technical Analysis of BGNE 2024-07-18
Overview
Analyzing the recent technical indicators for BGNE provides a comprehensive view of its potential price movements in the coming days. The data reflects a mix of bullish and bearish signals, indicating a complex market environment. By examining the trend, momentum, volatility, and volume indicators, we can derive insights that may guide ...
Recent News & Updates
- 2024-07-24 06:33
BeiGene opens biologics facility in New Jersey, US(Pharmaceutical Technology)
- 2024-07-23 11:59
- 2024-07-23 07:00
- 2024-07-22 19:00
- 2024-07-18 07:19
BeiGene Names Aaron Rosenberg CFO(MT Newswires)
- 2024-07-18 06:30
- 2024-07-17 18:30
- 2024-07-16 07:25
- 2024-07-12 07:14
When Will BeiGene, Ltd. (NASDAQ:BGNE) Become Profitable?(Simply Wall St.)
- 2024-06-27 03:16
- 2024-06-26 17:28
- 2024-06-25 04:06
- 2024-06-24 07:32
- 2024-06-21 03:09
- 2024-06-20 17:34
- 2024-06-14 07:48
- 2024-06-14 06:00
- 2024-06-13 19:41
- 2024-06-13 18:00
- 2024-06-13 07:41
- 2024-06-13 07:09
- 2024-06-04 06:01
- 2024-06-03 18:01
- 2024-05-29 07:07
7 Large-Cap Stocks That Can Jump 50% By 2025(InvestorPlace)
- 2024-05-28 19:07
7 Large-Cap Stocks That Can Jump 50% By 2025(Investorplace)
- 2024-05-28 11:49
- 2024-05-28 09:29
- 2024-05-28 08:00
- 2024-05-27 20:00
- 2024-05-24 08:36